Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
1994-11-23
pubmed:abstractText
The specificity of tetrafibricin was examined by comparing its activities on GPIIb/IIIa and on the vitronectin receptor (alpha v beta 3) with those of Arg-Gly-Asp-Ser (RGDS) on the same receptors. Tetrafibricin, which inhibited fibrinogen-GPIIb/IIIa binding 10 times more potently than RGDS, was three orders of magnitude less potent compared to RGDS on the inhibition of fibrinogen binding to alpha v beta 3. Furthermore, tetrafibricin potently inhibited platelet adhesion to both fibrinogen and von Willebrand factor. Whereas, there was no significant inhibition observed in the GPIIb/IIIa-independent cellular adhesions. These results suggest that tetrafibricin is highly selective for GPIIb/IIIa.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Anti-Bacterial Agents, http://linkedlifedata.com/resource/pubmed/chemical/Fibrinogen, http://linkedlifedata.com/resource/pubmed/chemical/Glycoproteins, http://linkedlifedata.com/resource/pubmed/chemical/Integrins, http://linkedlifedata.com/resource/pubmed/chemical/Macrolides, http://linkedlifedata.com/resource/pubmed/chemical/Oligopeptides, http://linkedlifedata.com/resource/pubmed/chemical/Platelet Aggregation Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Platelet Membrane Glycoproteins, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Cytoadhesin, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Vitronectin, http://linkedlifedata.com/resource/pubmed/chemical/Vitronectin, http://linkedlifedata.com/resource/pubmed/chemical/arginyl-glycyl-aspartyl-serine, http://linkedlifedata.com/resource/pubmed/chemical/tetrafibricin, http://linkedlifedata.com/resource/pubmed/chemical/von Willebrand Factor
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0006-291X
pubmed:author
pubmed:issnType
Print
pubmed:day
14
pubmed:volume
204
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
325-32
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:7524499-Amino Acid Sequence, pubmed-meshheading:7524499-Animals, pubmed-meshheading:7524499-Anti-Bacterial Agents, pubmed-meshheading:7524499-Aorta, pubmed-meshheading:7524499-Blood Platelets, pubmed-meshheading:7524499-Cattle, pubmed-meshheading:7524499-Cells, Cultured, pubmed-meshheading:7524499-Endothelium, Vascular, pubmed-meshheading:7524499-Fibrinogen, pubmed-meshheading:7524499-Glycoproteins, pubmed-meshheading:7524499-Humans, pubmed-meshheading:7524499-Integrins, pubmed-meshheading:7524499-Kinetics, pubmed-meshheading:7524499-Macrolides, pubmed-meshheading:7524499-Molecular Sequence Data, pubmed-meshheading:7524499-Oligopeptides, pubmed-meshheading:7524499-Platelet Adhesiveness, pubmed-meshheading:7524499-Platelet Aggregation Inhibitors, pubmed-meshheading:7524499-Platelet Membrane Glycoproteins, pubmed-meshheading:7524499-Receptors, Cytoadhesin, pubmed-meshheading:7524499-Receptors, Vitronectin, pubmed-meshheading:7524499-Vitronectin, pubmed-meshheading:7524499-von Willebrand Factor
pubmed:year
1994
pubmed:articleTitle
Tetrafibricin has a high selectivity for GPIIb/IIIa: comparison of the effects of tetrafibricin and RGDS on GPIIb/IIIa and the vitronectin receptor.
pubmed:affiliation
Nippon Roche Research Center, Kanagawa, Japan.
pubmed:publicationType
Journal Article, Comparative Study